MiR-29a/b Suppresses CD8+ T Cell Effector Function and Intestinal Inflammation
- Exploration (Beijing). 2025 Jun 10;5(4):20240363. doi: 10.1002/EXP.20240363.
- 1. College of Food Science and Nutritional Engineering China Agricultural University Beijing China.
- 2. Key Laboratory of Functional Dairy, Department of Nutrition and Health China Agricultural University Beijing China.
- 3. Nutrition and Health Research Center National Center of Technology Innovation for Dairy Hohhot China.
- 4. Department of Gastroenterology, Beijing Hospital, National Center of Gerontology Institute of Geriatric Medicine, Chinese Academy of Medical Science Beijing China.
- 5. Department of Obstetrics and Gynecology Columbia University New York New York USA.
- 6. Department of Health Sciences and Technology ETH Zurich Zurich Switzerland.
The role of CD8+ T cells in the pathogenesis of ulcerative colitis (UC) remains unclear. Similarly, the posttranscriptional regulation of the highly heterogenic CD8+ T cell populations and their effector function in IBD also remains poorly understood. Here, we find that miR-29a and -29b (miR-29a/b) regulate T cell fate, and their expression is higher near damaged colon tissue in patients with IBD compared to controls. In mice, we find that miR-29a/b suppresses the differentiation of CD8+ T cells and the secretion of pro-inflammatory and chemotactic factors during severe colitis by inhibiting transcriptional pathways, including those involving the T cell receptor and JAK-STAT signaling. Furthermore, we identify Ifng, an inflammatory factor that drives immune response and the reshaping of CD8+ T cell fate, as a potential target of the miRNAs. Finally, we show that delivery of miR-29 mimics to the colon of mice is sufficient to alleviate DSS-induced inflammation. Together, these data show that miR-29 plays an important role in suppressing T cell overactivation during inflammatory diseases.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Cancer